Pharmaceutical Industry Reports cytotoxic drugs market | Page 2
REPORT DESCRIPTION
Cytotoxic Drugs Market – Overview
The cytotoxic drugs market size is expected to grow significantly during the forecast timeframe, owing to
increasing incidences of cancer worldwide. According to World Health Organization’s (WHO) 2018 report,
around 9.6 million deaths were recorded due to cancer and around 18.1 million new cases of cancer were
diagnosed in 2018 worldwide.
Furthermore, increasing number of cytotoxic drug approvals is expected to boost the market growth. For instance,
in November 2018, the U.S. FDA approved Pfizer’s DAURISMO (glasdegib) in the U.S. for adult patients with
newly-diagnosed acute myeloid leukemia for whom intensive chemotherapy is not an option. Other potential
factor that contributes to cytotoxic drugs market revenue growth is increasing therapeutic area of cytotoxic drugs
in auto-immune conditions, rheumatoid arthritis, psoriasis, or prevention of transplant rejection because of its
immunosuppressive or anti–proliferative effects.
Cytotoxic drugs or cytostatics (cytotoxic chemotherapy) are agents used to destroy cancer cells and tumors by
inhibiting cell division. These drugs are widely used as anti-cancer agents and are used to boost the outcomes of
surgery or radiotherapy, reduce metastasis, and diminish cancer symptoms.